Abstract:Purpose: Super-refractory status epilepticus (SRSE) presents management challenges due to the absence of randomized controlled trials and a plethora of potential medical therapies. The literature on treatment options for SRSE reports variable success and quality of evidence. This review is a sequel to the 2020 American Epilepsy Society (AES) comprehensive review of the treatment of convulsive refractory status epilepticus (RSE). Methods: We sought to determine the effectiveness of treatment options for SRSE. We performed a structured literature search (MEDLINE, Embase, CENTRAL, CINAHL) for studies on reported treatments of SRSE. We excluded antiseizure medications (ASMs) covered in the 2016 AES guideline on the treatment of established SE and the convulsive RSE comprehensive review of the 2020 AES. Literature was reviewed on the effectiveness of vagus nerve stimulation, ketogenic diet (KD), lidocaine, inhalation anesthetics, brain surgery, therapeutic hypothermia, perampanel, pregabalin (PGB), and topiramate in the treatment of SRSE. Two authors reviewed each therapeutic intervention. We graded the level of the evidence according to the 2017 classification scheme of the American Academy of Neurology. Results: For SRSE (level U; 39 class IV studies total), insufficient evidence exists to support that perampanel, PGB, lidocaine, or acute vagus nerve stimulation (VNS) is effective. For children and adults with SRSE, insufficient evidence exists to support that the KD is effective (level U; 5 class IV studies). For adults with SRSE, insufficient evidence exists that brain surgery is effective (level U, 7 class IV studies). For adults with SRSE insufficient, evidence exists that therapeutic hypothermia is effective (level C, 1 class II and 4 class IV studies). For neonates with hypoxic-ischemic encephalopathy, insufficient evidence exists that therapeutic hypothermia reduces seizure burden (level U; 1 class IV study). For adults with SRSE, insufficient evidence exists that inhalation anesthetics are effective (level U, 1 class IV study) and that there is a potential risk of neurotoxicity. Conclusion: For patients with SRSE insufficient, evidence exists that any of the ASMs reviewed, inhalational anesthetics, ketogenic diet, acute VNS, brain surgery, and therapeutic hypothermia are effective treatments. Data supporting the use of these treatments for SRSE are scarce and limited mainly to small case series and case reports and are confounded by differences in patients' population, and comedications, among other factors.

Ni-Mo Nanocatalysts on N-Doped Graphite Nanotubes for Highly Efficient Electrochemical Hydrogen Evolution in Acid.

Chinese expert recommendations on ketogenic diet therapy for super-refractory status epilepticus

Implementation Concerns of Scholar-Practitioners: A Pilot Study of the Link between Research and Practice

The ketogenic diet for super-refractory status epilepticus patients in intensive care units

The Ketogenic Diet for Paediatric Patients with Super-Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome

Outcomes of parenteral vs enteral ketogenic diet in pediatric super-refractory status epilepticus

AXENIC CULTURE OF TETRATRICHOMONAS GALLINARUM: GROWTH AND ANAEROBIC UTILIZATION OF CARBOHYDRATES AND RELATED COMPOUNDS.

A retrospective study of 92 children with new-onset refractory status epilepticus

Clinical outcomes among initial survivors of cryptogenic new‐onset refractory status epilepsy (NORSE)

Effectiveness of the ketogenic diet used to treat resistant childhood epilepsy in Scandinavia

Ketogenic diet (KD) therapy in the acute phase of febrile infection-related epilepsy syndrome (FIRES): a case report

The Efficacy of a Ketogenic Diet in a Case With Febrile Infection-Related Epilepsy Syndrome in the Chronic Phase: A Case Report

Long-term outcome in new onset refractory status epilepticus: a retrospective study

Trends in management of patients with new‐onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis

Short-term effectiveness and side effects of ketogenic diet for drug-resistant epilepsy in children with genetic epilepsy syndromes

Pharmacological Analysis of the Novel, Rapid, and Potent Inactivation of the Human 5-Hydroxytryptamine7 Receptor by Risperidone, 9-OH-Risperidone, and Other Inactivating Antagonists

Ketogenic Dietary Therapy in Adult Status Epilepticus: Current Progress and Clinical Application

New Onset Refractory Status Epilepticus with diffuse cerebral restricted diffusion in young children; a novel clinical-radiologic presentation

Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study

NORSE/FIRES: how can we advance our understanding of this devastating condition?

Treatment of Super-Refractory Status Epilepticus: A Review